Pan Zheng

Affiliations: 
Yale University, New Haven, CT 
Google:
"Pan Zheng"

Children

Sign in to add trainee
Chong Chen grad student 2009 University of Michigan (Cell Biology Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Muthana MM, Du X, Liu M, et al. (2023) CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment. Elife. 12
Muthana MM, Du X, Liu M, et al. (2023) CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment. Biorxiv : the Preprint Server For Biology
Liu Y, Zheng P. (2019) Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. Trends in Pharmacological Sciences
Liu Y, Zheng P. (2019) Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. Trends in Pharmacological Sciences
Paluskievicz CM, Cao X, Abdi R, et al. (2019) T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology. 10: 2453
Paluskievicz CM, Cao X, Abdi R, et al. (2019) T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology. 10: 2453
Tao R, Murad N, Xu Z, et al. (2019) MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research
Tao R, Murad N, Xu Z, et al. (2019) MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research
Du X, Tang F, Liu M, et al. (2018) A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research
Du X, Tang F, Liu M, et al. (2018) A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research
See more...